| Report ID | 280966 |
| Drug Identification Number | 02556200 |
| Brand name | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN |
| Common or Proper name | Sitagliptin and Metformin Hydrochloride Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Bottle / Bouteille 180 |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-03-12 |
| Estimated end date | |
| Actual end date | 2026-04-10 |
| Shortage status | Actual shortage |
| Updated date | 2026-03-24 |
| Company comments | Other format available, Manufacturer delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-03-24 | French | Compare |
| v3 | 2026-03-24 | English | Compare |
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 4 of 4